Hyo-Soo Kim

3 weeks ago | healio.com | Scott Buzby |Richard Smith |Hyo-Soo Kim

Three months may be the ‘sweet spot’ for dual antiplatelet therapy after PCI• Dual antiplatelet therapy for 1 month was inferior to 3 months for patients with high bleeding risk after PCI. • DAPT for 3 months was superior to 12 months for patients with low bleeding risk. CHICAGO — Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low and high bleeding risk, compared with 1 and 12 months of DAPT, according to new data.

Sep 13, 2023 | specialty.mims.com | Hyo-Soo Kim

Patients with coronary artery disease (CAD) who have undergone percutaneous coronary intervention (PCI) and completed dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor typically receive aspirin as lifelong single antiplatelet therapy (SAPT). However, a growing body of evidence suggests that East Asian patients are prone to excess bleeding from antithrombotic therapy compared with their Western counterparts, and thus may require a different antithrombotic strategy.